Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD

Direct healthcare costs for patients with asthma are less than half (−52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP

Detalles Bibliográficos
Autores principales: Ronco, Raffaella, Franco, Giovanni, Monzio Compagnoni, Matteo, Aliberti, Stefano, Luppi, Fabrizio, Corrao, Giovani, Faverio, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388176/
https://www.ncbi.nlm.nih.gov/pubmed/37529638
http://dx.doi.org/10.1183/23120541.00158-2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388176/
https://www.ncbi.nlm.nih.gov/pubmed/37529638
http://dx.doi.org/10.1183/23120541.00158-2023

Ejemplares similares